Andreas Pahl

Andreas Pahl

Chief Executive Officer at
Heidelberg Pharma Research GmbH
Health Technology
Consumer Services
Commercial Services

Profile

Andreas Pahl is currently Managing Director at Heidelberg Pharma Research GmbH since 2024.
Former positions include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member of the Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.

Andreas Pahl active positions

CompaniesPositionStart
Chief Executive Officer 01/02/2024

Former positions of Andreas Pahl

CompaniesPositionEnd
HEIDELBERG PHARMA AG Chief Executive Officer 24/11/2025
Corporate Officer/Principal -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal -
Director/Board Member -
Corporate Officer/Principal -
See the detail of Andreas Pahl's experience

Training of Andreas Pahl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology